MedPath

Iniparib

Generic Name
Iniparib
Drug Type
Small Molecule
Chemical Formula
C7H5IN2O3
CAS Number
160003-66-7
Unique Ingredient Identifier
2ZWI7KHK8F

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
2012/05/08
NCT01593228
Phase 3
Completed
Sanofi
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
2011/10/20
NCT01455532
Phase 1
Completed
Sanofi
Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors
2010/10/04
NCT01213381
Phase 1
Completed
Sanofi
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients
2010/09/17
NCT01204125
Phase 2
Completed
Sanofi
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
2010/08/02
NCT01173497
Phase 2
Completed
Sanofi
An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)
2010/07/14
NCT01161836
Phase 1
Completed
Sanofi
An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
2010/05/25
NCT01130259
N/A
NO_LONGER_AVAILABLE
Sanofi
SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer
2010/03/15
NCT01086254
Phase 2
Completed
Sanofi
Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)
2010/03/08
NCT01082549
Phase 3
Completed
Sanofi
Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer
2010/01/11
NCT01045304
Phase 2
Completed
Sanofi

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy